Association between Antibodies to the MR 67,000 Isoform of Glutamate Decarboxylase (GAD) and Type 1 (Insulin-Dependent) Diabetes Mellitus with Coexisting Autoimmune Polyendocrine Syndrome Type II

References

• Bottazzo G. F, Doniach D. Polyendocrine autoimmunity: an extended concept. Autoimmunity and endocrine disease, R. Volpe. Marcel/Dekker Inc., New York 1985; 375–403
   Google Scholar
• Bottazzo G. F., Todd I., Mirakian R., Belfiore A., Pujol-Borrell R. Organ-specific autoimmunity. A 1986 overview. Immunol. Rev. 1986; 94: 137–169
   PubMed Web of Science ®Google Scholar
• Muir A., MacLaren N. K. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. Endorin. Metab. Clin. 1993; 20: 619–643
   Google Scholar
• Banga J. P., Barnett P. S., Mahadevan D., McGregor A. M. Immune recognition of antigen and its relevance to autoimmune disease: recent advances on the molecular level. Europ. J. Clin. Invest. 1989; 19: 107–116
   PubMed Web of Science ®Google Scholar
• Tarn A. C., Thomas J. M., Dean B. M., et al. Predicting insulin-dependent diabetes. Lancet 1988; 845–850
   Google Scholar
• Riley W. J., MacLaren N. K., Kirscher J., Spillar R. P., Silverstein J. H., Schatz D. A., et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 1990; 323: 1167–1172
   PubMed Web of Science ®Google Scholar
• Genovese S., Bonifacio E., McNally J. M., Dean B. M., Wagner R., Bosi E., et al. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992; 35: 385–388
   PubMed Web of Science ®Google Scholar
• Scherbaum W. A. Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens. Clin. Endocrin. 1994; 40: 15–18
   Google Scholar
• Richter W., Seissler J., Northemann W., Wolfahrt S., Meinck H. M., Scherbaum W. A. Cytoplasmic islet cell antibodies recognize distinct antigens in IDDM but not in Stiff Man Syndrome. Diabetes 1993; 42: 1642–1648
   Google Scholar
• Baekkeskov S., Aanstoot A. J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Karlsen A. E., Hagopian W. A., Grubin C. E., Dube S., Distech C. M., Adler D. A., et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl Acad. Sci. 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Seissler J., Amann J., Mauch L, Haubruck H., Wolfahrt S., Bieg S., et al. Prevalence of autoantibodies to the 65-and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1993; 92: 1394–1399
   PubMed Web of Science ®Google Scholar
• Hagopan W. A., Michelsen B., Karlsen A. E., Larsen F., Moody A., Grubin C. E., et al. Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631–636
   Google Scholar
• Solimena M., Folli F., Aparisi R., Pozza G., de Camilli P. Autoantibodies to GABA-eric neurons and pancreatic beta cells in Stiff-Man Syndrome. N. Engl. J. Med. 1990; 322: 1555–1560
   PubMed Web of Science ®Google Scholar
• Mauch L., Seissler J., Haubruck H., Cook N., Abney C. C., Berthold H., et al. Baculovirus mediated expression of human 65a and 67 KDa glutamic acid decarboxylase in SF9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus. J. Biochem. 1993; 113: 699–704
   PubMed Web of Science ®Google Scholar
• Schmidli R TS, Colman P. G., Bonifacio E., Bottazzo G. F., Harrison L. C. High level of concordance between assays for glutamic acid decarboxylase antibodies. The first interbational glutamic acid decarboxylase antibody workshop. Diabetes 1994; 43: 1005–1009
   PubMed Web of Science ®Google Scholar
• Scherbaum W. A., Mirakian A. R., Pujol-Borrell R., Dean M., Bottazzo G. F. Immunochemistry in the study and diagnosis of organ-specific autoimmune diseases. Immunochemistry. Modern Methods and Applications, J. M. Polak, S. Van Noorden. Wirght, Bistrol 1986; 456–476
   Google Scholar
• Betterle C. F., Zanette F., Pedini B., Presotto F., Rapp L. B., Monciotto C. M., et al. Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first degree relatives. Diabetologia. 1984; 26: 431–436
   Google Scholar
• Bjork E., Velloso L. A., Kampe O., Karlsson F. A. GAD autoantibodies in IDDM. Stiff-Man Syndrome and autoimmune polyendocrine syndrome Type I recognize different epitopes. Diabetes 1993; 43: 161–165
   Google Scholar
• Velloso L. A., Winqvist O., Gustafsson J., Kampe O., Karlsson F. A. Autoantibodies against a novel 51 KDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome Type 1. Diabetologia. 1994; 37: 61–69
   PubMed Web of Science ®Google Scholar
• Kim J., Richter W., Aanstoot H. J., Beakkeskov S. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 1993; 42: 1799–1808
   PubMed Web of Science ®Google Scholar
• Christie M. R., Brown T. J., Cassidy D. Binding of autoantibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia. 1992; 35: 380–384
   PubMedGoogle Scholar
• Ujihara N., Daw K., Gianini R., Boel E., Yu L., Powers A. C. Identification of glutamic acid decarboxylase autoanti-body heterogeneity and epitope regions in Type 1 diabetes. Diabetes 1994; 43: 968–975
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43: 80–86.S.
   PubMedGoogle Scholar
• Wagner R., Genovese S., Bosi E., Becker F., Singly P. J., Bonifacio E., et al. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease. Diabetologia. 1994; 37: 365–371
   Google Scholar
• Wagner R., McNally J. M., Bonifacio E., Genovese S., Foulis A., McGill M., et al. Lack of immunohistochemical changes in the islets of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet cell antibodies. Diabetes 1994; 43: 851–856
   PubMed Web of Science ®Google Scholar